Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Cash & Equivalents (2019 - 2026)

IM Cannabis has reported Cash & Equivalents over the past 8 years, most recently at $732122.5 for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 21.73% year-over-year to $732122.5; the TTM value through Mar 2026 reached $732122.5, up 21.73%, while the annual FY2025 figure was $2.0 million, 210.23% up from the prior year.
  • Cash & Equivalents was $732122.5 for Q1 2026 at IM Cannabis, down from $2.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $2.0 million in Q4 2025 and bottomed at $255971.4 in Q2 2024.
  • The 5-year median for Cash & Equivalents is $732122.5 (2026), against an average of $1.0 million.
  • Year-over-year, Cash & Equivalents crashed 83.64% in 2022 and then skyrocketed 216.54% in 2025.
  • Over 5 years, Cash & Equivalents stood at $1.8 million in 2022, then fell by 26.19% to $1.3 million in 2023, then tumbled by 53.61% to $617777.8 in 2024, then skyrocketed by 216.54% to $2.0 million in 2025, then tumbled by 62.56% to $732122.5 in 2026.
  • The last three reported values for Cash & Equivalents were $732122.5 (Q1 2026), $2.0 million (Q4 2025), and $601438.9 (Q1 2025) per Business Quant data.